Citation: R. Murata et al., Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues, INT J RAD B, 77(2), 2001, pp. 195-204
Authors:
Overgaard, J
Schiott, B
Larsen, FK
Iversen, BB
Citation: J. Overgaard et al., The charge density distribution in a model compound of the catalytic triadin serine proteases, CHEM-EUR J, 7(17), 2001, pp. 3756-3767
Citation: R. Murata et al., Combretastatin A-4 disodium phosphate: A vascular targeting agent that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy, INT J RAD O, 51(4), 2001, pp. 1018-1024
Authors:
Alsner, J
Hoyer, M
Sorensen, SB
Overgaard, J
Citation: J. Alsner et al., Interaction between potential doubling time and TP53 mutation: Predicting radiotherapy outcome in squamous cell carcinoma of the head and neck, INT J RAD O, 49(2), 2001, pp. 519-525
Citation: Mr. Horsman et al., Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation, ACTA ONCOL, 40(4), 2001, pp. 497-503
Citation: R. Murata et al., Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid, INT J HYPER, 17(6), 2001, pp. 508-519
Authors:
Murata, R
Siemann, DW
Overgaard, J
Horsman, MR
Citation: R. Murata et al., Interaction between combretastatin A-4 disodium phosphate and radiation inmurine tumors, RADIOTH ONC, 60(2), 2001, pp. 155-161
Citation: J. Alsner et al., TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck, RADIOTH ONC, 59(2), 2001, pp. 179-185
Authors:
Murata, R
Siemann, DW
Overgaard, J
Horsman, MR
Citation: R. Murata et al., Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid, RADIAT RES, 156(5), 2001, pp. 503-509
Authors:
Nielsen, FU
Daugaard, P
Bentzen, L
Stodkilde-Jorgensen, H
Overgaard, J
Horsman, MR
Maxwell, RJ
Citation: Fu. Nielsen et al., Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy, CANCER RES, 61(13), 2001, pp. 5318-5325
Authors:
Nordsmark, M
Alsner, J
Keller, J
Nielsen, OS
Jensen, OM
Horsman, MR
Overgaard, J
Citation: M. Nordsmark et al., Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations, BR J CANC, 84(8), 2001, pp. 1070-1075
Citation: M. Borre et al., Association between immunohistochemical expression of vascular endothelialgrowth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting, CLIN CANC R, 6(5), 2000, pp. 1882-1890
Authors:
Alsner, J
Yilmaz, M
Guldberg, P
Hansen, LL
Overgaard, J
Citation: J. Alsner et al., Heterogeneity in the clinical phenotype of TP53 mutations in breast cancerpatients, CLIN CANC R, 6(10), 2000, pp. 3923-3931
Authors:
Dikomey, E
Brammer, I
Johansen, J
Bentzen, SM
Overgaard, J
Citation: E. Dikomey et al., Relationship between DNA double-strand breaks, cell killing, and fibrosis studied in confluent skin fibroblasts derived from breast cancer patients, INT J RAD O, 46(2), 2000, pp. 481-490
Citation: Lv. Johansen et al., Squamous cell carcinoma of the oropharynx - An analysis of treatment results in 289 consecutive patients, ACTA ONCOL, 39(8), 2000, pp. 985-994
Authors:
Bentzen, L
Keiding, S
Horsman, MR
Falborg, L
Hansen, SB
Overgaard, J
Citation: L. Bentzen et al., Feasibility of detecting hypoxia in experimental mouse tumours with F-18-fluorinated tracers and positron emission tomography - A study evaluating [F-18]fluoromisonidazole and [F-18]fluoro-2-deoxy-D-glucose, ACTA ONCOL, 39(5), 2000, pp. 629-637
Citation: J. Overgaard, Management of the axilla in breast cancer. Implication for diagnosis, prognosis, treatment, and morbidity, ACTA ONCOL, 39(3), 2000, pp. 259-260